Hackensack Meridian Health - JFK Johnson Rehabilitation Institute
Edison, New Jersey, 08820, United States
Location status: Recruiting
NCT Number: NCT05651945
This study examines the effectiveness of the cardiac rehabilitation program for stroke patients. The study will examine if patients with stroke, who receive cardiac rehabilitation in addition to their standard of care treatments, demonstrate improved recovery of function. It will also examine if these patients have reduced hospital readmission, reduced rate of recurrent stroke, and mortality.
Interested in participating?
Request Info18 year and older
All sexes
Interventional
Not applicable
Edison, New Jersey, 08820, United States
Location status: Recruiting
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The cardiac rehabilitation program is an outpatient exercise intervention consisting of 36 sessions (30-50 minutes) of a progressive exercise program. Participants are closely monitored throughout the sessions using a telemetry monitor and are supervised by a team of cardiac rehabilitation nurses and exercise physiologists. In addition to the exercise program, participants will receive educational sessions for cardiovascular disease (CVD) risk factors including: 1) Diet/Nutrition, 2) Smoking cessation, 3) Physical activity, 4) Medication management/adherence and 5) Behavior change. As a part of the program, based on the initial assessment results, patients are referred to a rehabilitation psychologist or a dietician for consultation and evaluation if needed. In addition, participants will also receive their standard of care therapies as prescribed by their treating physicians.
Time frame: Change from Baseline (30 days post-stroke) to 120 days post-stroke.
Mean change in 6MWT score from baseline (30 days post-stroke) to 120 days post-stroke.
Time frame: Change from Baseline (30 days post-stroke) to 120 days post-stroke.
Mean change in MET-min score from baseline (30 days post-stroke) to 120 days post-stroke.
Time frame: Change from Baseline (30 days post-stroke) to 120 days post-stroke.
Mean change in AM-PAC score from baseline (30 days post-stroke) to 120 days post-stroke. AM-PAC is a questionnaire that evaluates functional outcomes across three domains: basic mobility, daily activity, and applied cognitive. Standardized scores range from -11.95 to 104.9 for basic mobility, from -2.73 to 115.4 for daily activities, and from 6.84 to 68.28 for applied cognition with higher scores representing a better function.
Time frame: Change from Baseline (30 days post-stroke) to 120 days post-stroke.
Mean change in 10MWT score from baseline (30 days post-stroke) to 120 days post-stroke.
Time frame: Change from Baseline (30 days post-stroke) to 120 days post-stroke.
Mean change in MoCA score from baseline (30 days post-stroke) to 120 days post-stroke. MoCA is a 16-item test assessing multiple cognitive domains with a score range from 0-30 with higher scores representing a better function.
Time frame: Change from Baseline (30 days post-stroke) to 120 days post-stroke
Mean change in SS-QOL score from baseline (30 days post-stroke) to 120 days post-stroke. SS-QOL is a self-reported questionnaire containing 49 item questions covering 12 domains with a score range of 49-245 with higher scores representing better function.
Time frame: Change from Baseline (30 days post-stroke) to 120 days post-stroke
Mean change in PHQ-9 score from baseline (30 days post-stroke) to 120 days post-stroke. The PHQ-9 is a self-administered questionnaire designed to diagnose and evaluate depression with a score range 0-27.
Time frame: 1-year post-stroke
All-cause hospital readmission rates at 1-year post-stroke
Time frame: 1-year post stroke
Recurrent stroke rates at 1-year post stroke
Time frame: 1-year post stroke
All-cause mortality rates at 1-year post stroke
Time frame: 1-year post stroke
Mean change in AM-PAC score from baseline (30 days post stroke) to 1-year post stroke. AM-PAC is a questionnaire that evaluates functional outcomes across three domains: basic mobility, daily activity, and applied cognitive. Standardized scores range from -11.95 to 104.9 for basic mobility, from -2.73 to 115.4 for daily activities, and from 6.84 to 68.28 for applied cognition with higher scores representing a better function.
Time frame: 1-year post stroke
Mean change in SS-QOL score from baseline (30 days post stroke) to 1-year post stroke. SS-QOL is a self-reported questionnaire containing 49 item questions covering 12 domains with a score range of 49-245 with higher scores representing better function.
Time frame: Change from Baseline (30 days post stroke) to 120 days post stroke
Mean change in mRS score from baseline (30 days post stroke) to 120 days post stroke. The mRS is a questionnaire to assess the level of disability and functional independence in daily activities with reference to pre-stroke activities. The scale is scored 0-6 where 0 indicates lack of symptoms and the score 6 indicates death.
Time frame: Change from Baseline (30 days post stroke) to 120 days post stroke
Mean change in PYP score from baseline (30 days post stroke) to 120 days post stroke. Picture Your Plate is a brief 48-question dietary assessment questionnaire with a total score ranging from 0 to 96 with higher scores representing an unhealthy diet.
Contact information is provided by the study sponsor or research team.
Hackensack Meridian Health
Other
Stroke Recovery Program-Cardiac Rehabilitation of Stroke Survivors
Acronym: SRP-CROSS
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06124248
Behavior, Brain Diseases
's-Hertogenbosch, North Brabant, Netherlands
View Trial DetailsNCT02425345
Arterial Occlusive Diseases, Arteriosclerosis
View Trial DetailsNCT04663685
Arthritis, Behavior
Waterloo, Canada
View Trial DetailsNCT04232163
Behavior, Brain Diseases
Calgary, Alberta, Canada
View Trial Details